Dabrafenib Mesylate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

18 API Suppliers, 1 USDMF, 1 EU WC, 3 NDC API, 15 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

10 Drugs in Development

10 Drugs in Development

INTERMEDIATES

18 Intermediate Suppliers

18 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

21 FDF Dossiers, 5 FDA Orange Book, 5 Europe, 3 Canada, 6 Australia, 2 South Africa

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - EQ 50MG BASE, CAPSULE;ORAL - EQ 75MG BASE

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 5 DKSH, 1 Faran Shimi Pharmaceutical, 2 Gangwal Healthcare, 1 ACG Worldwide, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 Corel Pharma Chem, 2 DFE Pharma, 6 Gangwal Chemicals, 4 Ideal Cures, 15 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 8 Microlex e.U, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 1 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 9 Roquette, 6 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 8 Sigachi Industries, 2 Silverline Chemicals, 2 The Dow Chemical Company, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

42 Coating Systems & Additives, 21 Fillers, Diluents & Binders, 19 Controlled & Modified Release, 12 Thickeners and Stabilizers, 10 Lubricants & Glidants, 10 Co-Processed Excipients, 9 Direct Compression, 7 Granulation, 6 Film Formers & Plasticizers, 5 Empty Capsules, 5 Disintegrants & Superdisintegrants, 4 Coloring Agents, 4 Rheology Modifiers, 4 Emulsifying Agents, 4 Vegetarian Capsules, 4 Taste Masking, 4 API Stability Enhancers, 3 Chewable & Orodispersible Aids, 1 Solubilizers